Literature DB >> 27173221

MMP-9 genetic polymorphism may confer susceptibility to COPD.

S Jiang1, Z H Yang1, Y Y Chen1, Z He1, Y Zhou1, Y Gao1, Q Zhang1, M Q Tan1.   

Abstract

Correlations between genetic polymorphisms of three matrix metalloproteinase (MMP) genes and susceptibility to chronic obstructive pulmonary disease (COPD) were investigated. Relevant case-control studies were selected using rigorous inclusion and exclusion criteria. The comprehensive Meta-analysis 2.0 software was used to conduct the statistical analysis. An odds ratio with 95% confidence intervals was applied to assess the correlation between genetic polymorphisms of MMPs and susceptibility to COPD. Twelve high-quality studies were selected for inclusion in this meta-analysis. These studies included a combined total of 1533 COPD patients and 1530 healthy controls. The result of the meta-analysis showed that MMP-9 rs3918242 C > T was significantly correlated with increased susceptibility to COPD. However, MMP-1 rs1799750 1G > 2G and MMP-3 rs3025058 5A > 6A were not associated with COPD risk (all P > 0.05). Based on our meta-analysis, MMP-9 rs3918242 C > T is correlated with susceptibility to COPD, but MMP-1 rs1799750 1G > 2G and MMP-3 rs3025058 5A > 6A are not. These results should be further confirmed using a larger sample size.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27173221     DOI: 10.4238/gmr.15026272

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  9 in total

Review 1.  Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies.

Authors:  Stanley M H Chan; Stavros Selemidis; Steven Bozinovski; Ross Vlahos
Journal:  Pharmacol Ther       Date:  2019-02-26       Impact factor: 12.310

Review 2.  Genetic Variants Associated with Chronic Obstructive Pulmonary Disease Risk: Cumulative Epidemiological Evidence from Meta-Analyses and Genome-Wide Association Studies.

Authors:  Caiyang Liu; Ran Ran; Xiaoliang Li; Gaohua Liu; Xiaoyang Xie; Ji Li
Journal:  Can Respir J       Date:  2022-06-09       Impact factor: 2.130

Review 3.  Genetic polymorphism and chronic obstructive pulmonary disease.

Authors:  Cunhua Yuan; Guangming Lu; Xiaowei Deng
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-05-10

4.  Proteolytic biomarkers are related to prognosis in COPD- report from a population-based cohort.

Authors:  Robert Linder; Eva Rönmark; Jamshid Pourazar; Annelie F Behndig; Anders Blomberg; Anne Lindberg
Journal:  Respir Res       Date:  2018-04-12

5.  Association of Surfactant-Associated Protein D Gene Polymorphisms with the Risk of COPD: a Meta-Analysis.

Authors:  Yi Liao; ChengLiang Huang; JianRong Wang; XianMing Fan
Journal:  Clinics (Sao Paulo)       Date:  2019-05-16       Impact factor: 2.365

6.  Expression of matrix metalloproteinase-9 in gingival tissue biopsy in patients with slowly/ moderately and rapidly progressing periodontitis: An observational study.

Authors:  Papita Ghosh; Thamil Selvan Muthuraj; Prasanta Bandyopadhyay; Snehasikta Swarnakar; Puja Sarkar; Abinaya Varatharajan
Journal:  J Indian Soc Periodontol       Date:  2021-08-30

7.  Genetic polymorphism of matrix metalloproteinase 9 and susceptibility to chronic obstructive pulmonary disease: A meta-analysis.

Authors:  Xiaoping Yang; Yuanyuan Yu; Yong Wang; Wen Jiang; Wenqing Jiang; Bin Yin
Journal:  J Med Biochem       Date:  2022-07-29       Impact factor: 2.157

8.  Role of matrix metalloproteases 1/3 gene polymorphisms in patients with rotator cuff tear.

Authors:  Kaisong Miao; Lifeng Jiang; Xindie Zhou; Lidong Wu; Yong Huang; Nanwei Xu; Junjie Zhang; Jin Li
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

9.  Increased MMP8 Levels in Atopic Chronic Obstructive Pulmonary Disease: A Study Testing Multiple Immune Factors in Atopic and Non-Atopic Patients.

Authors:  Haisheng Hu; Chuanxu Cai; Huimin Huang; Mingshan Xue; Jiaying Luo; Chenxi Liao; Baoqing Sun
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-07-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.